![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Chem. , 26 November 2019
Sec. Medicinal and Pharmaceutical Chemistry
Volume 7 - 2019 | https://doi.org/10.3389/fchem.2019.00804
This article is part of the Research Topic Prostate Cancer: Molecular Entities Targeting This Challenging Disease View all 9 articles
A retraction of this article was approved in:
Retraction: Corrigendum: Design, synthesis, and biological evaluation of (E)-N'-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents
Citation: Arjun HA, Elancheran R, Manikandan N, Lakshmithendral K, Ramanathan M, Bhattacharjee A, Lokanath NK and Kabilan S (2019) Corrigendum: Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents. Front. Chem. 7:804. doi: 10.3389/fchem.2019.00804
Received: 23 October 2019; Accepted: 07 November 2019;
Published: 26 November 2019; Retracted: 08 November 2023.
Edited and reviewed by: Greta Varchi, Consiglio Nazionale delle Ricerche (Bologna), Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.